Department of Thoracic Surgery, Aix-Marseille University, North Hospital, Marseille, France.
Department of Gastrointestinal Surgery, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
JAMA Surg. 2021 Sep 1;156(9):836-845. doi: 10.1001/jamasurg.2021.2376.
Ninety-day mortality rates after esophagectomy are an indicator of the quality of surgical oncologic management. Accurate risk prediction based on large data sets may aid patients and surgeons in making informed decisions.
To develop and validate a risk prediction model of death within 90 days after esophagectomy for cancer using the International Esodata Study Group (IESG) database, the largest existing prospective, multicenter cohort reporting standardized postoperative outcomes.
DESIGN, SETTING, AND PARTICIPANTS: In this diagnostic/prognostic study, we performed a retrospective analysis of patients from 39 institutions in 19 countries between January 1, 2015, and December 31, 2019. Patients with esophageal cancer were randomly assigned to development and validation cohorts. A scoring system that predicted death within 90 days based on logistic regression β coefficients was conducted. A final prognostic score was determined and categorized into homogeneous risk groups that predicted death within 90 days. Calibration and discrimination tests were assessed between cohorts.
Esophageal resection for cancer of the esophagus and gastroesophageal junction.
All-cause postoperative 90-day mortality.
A total of 8403 patients (mean [SD] age, 63.6 [9.0] years; 6641 [79.0%] male) were included. The 30-day mortality rate was 2.0% (n = 164), and the 90-day mortality rate was 4.2% (n = 353). Development (n = 4172) and validation (n = 4231) cohorts were randomly assigned. The multiple logistic regression model identified 10 weighted point variables factored into the prognostic score: age, sex, body mass index, performance status, myocardial infarction, connective tissue disease, peripheral vascular disease, liver disease, neoadjuvant treatment, and hospital volume. The prognostic scores were categorized into 5 risk groups: very low risk (score, ≥1; 90-day mortality, 1.8%), low risk (score, 0; 90-day mortality, 3.0%), medium risk (score, -1 to -2; 90-day mortality, 5.8%), high risk (score, -3 to -4: 90-day mortality, 8.9%), and very high risk (score, ≤-5; 90-day mortality, 18.2%). The model was supported by nonsignificance in the Hosmer-Lemeshow test. The discrimination (area under the receiver operating characteristic curve) was 0.68 (95% CI, 0.64-0.72) in the development cohort and 0.64 (95% CI, 0.60-0.69) in the validation cohort.
In this study, on the basis of preoperative variables, the IESG risk prediction model allowed stratification of an individual patient's risk of death within 90 days after esophagectomy. These data suggest that this model can help in the decision-making process when esophageal cancer surgery is being considered and in informed consent.
食管癌手术后 90 天死亡率是外科肿瘤治疗质量的指标。基于大型数据集的准确风险预测可以帮助患者和外科医生做出明智的决策。
使用国际食管数据研究组(IESG)数据库,这是最大的现有前瞻性、多中心队列报告标准化术后结果的数据库,开发和验证用于癌症的食管癌手术后 90 天内死亡的风险预测模型。
设计、设置和参与者:在这项诊断/预后研究中,我们对 19 个国家的 39 个机构在 2015 年 1 月 1 日至 2019 年 12 月 31 日期间的患者进行了回顾性分析。患者患有食管癌,被随机分配到发展和验证队列中。基于逻辑回归β系数的评分系统被用于预测 90 天内的死亡。确定最终的预后评分并将其分为预测 90 天内死亡的同质风险组。在队列之间评估校准和判别测试。
食管癌和胃食管交界处的癌症行食管切除术。
所有原因术后 90 天死亡率。
共纳入 8403 例患者(平均[SD]年龄,63.6[9.0]岁;6641[79.0%]为男性)。30 天死亡率为 2.0%(n=164),90 天死亡率为 4.2%(n=353)。开发(n=4172)和验证(n=4231)队列被随机分配。多变量逻辑回归模型确定了 10 个加权点变量,这些变量被纳入预后评分:年龄、性别、体重指数、身体状况、心肌梗死、结缔组织疾病、外周血管疾病、肝脏疾病、新辅助治疗和医院容量。预后评分被分为 5 个风险组:极低风险(评分≥1;90 天死亡率 1.8%)、低风险(评分 0;90 天死亡率 3.0%)、中风险(评分-1 至-2;90 天死亡率 5.8%)、高风险(评分-3 至-4:90 天死亡率 8.9%)和极高风险(评分≤-5;90 天死亡率 18.2%)。该模型在 Hosmer-Lemeshow 检验中没有显著性。该模型在发展队列中的判别(受试者工作特征曲线下面积)为 0.68(95%CI,0.64-0.72),在验证队列中的判别为 0.64(95%CI,0.60-0.69)。
在这项研究中,基于术前变量,IESG 风险预测模型允许对食管癌手术后 90 天内个体患者的死亡风险进行分层。这些数据表明,该模型可以帮助在考虑食管癌手术时的决策过程,并在知情同意时提供帮助。